Jilin Aodong Pharmaceutical Group Co Ltd (000623) — Cash Flow Reinvestment Rate
Jilin Aodong Pharmaceutical Group Co Ltd (000623) has a Cash Flow Reinvestment Rate of 0.23x as of September 2025, reinvesting CN¥25.80 Million (capex CN¥25.80 Million ) from operating cash flow of CN¥112.12 Million. Explore reinvestment intensity of Jilin Aodong Pharmaceutical Group Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jilin Aodong Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate (1999–2024)
Historical reinvestment intensity for Jilin Aodong Pharmaceutical Group Co Ltd across 25 annual periods. Also explore 000623 total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Jilin Aodong Pharmaceutical Group Co Ltd (1999–2024)
Year-by-year capital reinvestment analysis for Jilin Aodong Pharmaceutical Group Co Ltd. For live market cap and broader valuation context, see 000623 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 16.48x | CN¥980.49 Million | CN¥59.48 Million | CN¥273.98 Million | ▼ -5.2% |
| 2023 | 17.38x | CN¥1.18 Billion | CN¥68.06 Million | CN¥419.52 Million | ▲ +432.8% |
| 2022 | 3.26x | CN¥1.38 Billion | CN¥423.86 Million | CN¥270.97 Million | ▼ -24.0% |
| 2021 | 4.29x | CN¥1.39 Billion | CN¥324.85 Million | CN¥313.30 Million | ▲ +417.1% |
| 2020 | 0.83x | CN¥323.95 Million | CN¥390.41 Million | CN¥227.38 Million | ▼ -4.3% |
| 2019 | 0.87x | CN¥328.96 Million | CN¥379.46 Million | CN¥222.40 Million | ▼ -87.2% |
| 2018 | 6.76x | CN¥2.35 Billion | CN¥347.64 Million | CN¥245.30 Million | ▲ +217.9% |
| 2017 | 2.13x | CN¥545.48 Million | CN¥256.49 Million | CN¥83.93 Million | ▼ -3.8% |
| 2016 | 2.21x | CN¥738.12 Million | CN¥333.81 Million | CN¥158.03 Million | ▼ -40.3% |
| 2015 | 3.70x | CN¥1.44 Billion | CN¥388.03 Million | CN¥334.11 Million | ▲ +166.0% |
| 2014 | 1.39x | CN¥402.01 Million | CN¥288.83 Million | CN¥402.01 Million | ▼ -9.4% |
| 2013 | 1.54x | CN¥309.01 Million | CN¥201.22 Million | CN¥309.01 Million | ▲ +28.0% |
| 2012 | 1.20x | CN¥326.80 Million | CN¥272.40 Million | CN¥326.80 Million | ▼ -71.6% |
| 2011 | 4.23x | CN¥457.72 Million | CN¥108.30 Million | CN¥457.72 Million | ▲ +384.4% |
| 2010 | 0.87x | CN¥152.00 Million | CN¥174.22 Million | CN¥152.00 Million | ▲ +409.0% |
| 2009 | 0.17x | CN¥36.51 Million | CN¥213.03 Million | CN¥36.51 Million | ▲ +27.8% |
| 2008 | 0.13x | CN¥31.52 Million | CN¥235.03 Million | CN¥31.52 Million | ▲ +31.5% |
| 2007 | 0.10x | CN¥39.24 Million | CN¥384.69 Million | CN¥39.24 Million | ▼ -66.3% |
| 2006 | 0.30x | CN¥56.87 Million | CN¥187.99 Million | CN¥56.87 Million | ▼ -26.0% |
| 2005 | 0.41x | CN¥55.68 Million | CN¥136.26 Million | CN¥55.68 Million | ▲ +93.4% |
| 2004 | 0.21x | CN¥46.19 Million | CN¥218.53 Million | CN¥46.19 Million | ▼ -66.0% |
| 2003 | 0.62x | CN¥91.89 Million | CN¥147.65 Million | CN¥91.89 Million | ▼ -58.4% |
| 2001 | 1.49x | CN¥207.37 Million | CN¥138.76 Million | CN¥207.37 Million | ▼ -29.8% |
| 2000 | 2.13x | CN¥163.90 Million | CN¥77.04 Million | CN¥163.90 Million | ▲ +232.4% |
| 1999 | 0.64x | CN¥70.52 Million | CN¥110.18 Million | CN¥70.52 Million | — |